Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01843062
Title Study Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

thyroid gland cancer

Therapies

Selumetinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.